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ABSTRACT 
A PROSPECTIVE CASE CONTROL STUDY TO DETERMINE RISK FACTORS 
AND MORTALITY IN CHILDREN WITH CARBAPENEM RESISTANT 
ORGANISM SEPSIS 
BACKGROUND: Sepsis due to carbapenem-resistant organisms (CRO) is now reported 
from all over the world, and children are especially vulnerable to these deadly organisms. 
Although there are numerous studies in adults and neonates about CRO sepsis, prospective 
studies from the pediatric population from the Indian subcontinent are lacking. This study 
was hence undertaken to study the risk factors and outcomes including mortality in 
pediatric CRO sepsis.  
OBJECTIVES: Primary objective of the study was to compare mortality due to CRO sepsis 
with carbapenem-susceptible (CSO) sepsis. Secondary objectives were to look at risk 
factors for acquiring CRO sepsis and to compare severity of outcomes between these 
groups. 
METHODS: This was a prospective case-control study of all children with gram-negative 
sepsis admitted to the pediatric wards and Pediatric ICU/HDU of the Christian Medical 
College, Vellore, from January 2015 to May 2016. Children with CRO sepsis were 
included as cases and those with CSO sepsis as controls, in a 1:2 case: control ratio. 
Neonates, children who were not admitted, duplicated and insignificant or contaminant 
cultures were excluded.   
RESULTS: There were 224 children with gram-negative sepsis, of whom 89 had CRO 
sepsis and 135 had CSO sepsis.   
Non-fermenting gram-negative bacteria (NFGNB) including Acinetobacter and 
Pseudomonas were more common than Enterobacteriaceae (63.4% vs. 34.3%).Children 
with CRO sepsis were significantly more likely to have been admitted to ICU and 
undergone procedures such as ventilation [OR 7.2, 95% CI 3.6 to 14.1], urinary 
catheterization [OR 2.6, 95% CI 1.5 to 4.5] and central venous line placement [OR 4, 95% 
CI 2.3 to 7.1]. Children with CRO sepsis had a significantly higher risk of developing 
ventilator-associated pneumonia [OR 4.2, 95% CI 2.1 to 8.5], septic shock requiring 
inotropic support and multi-organ dysfunction [OR 5.4, 95% CI 2.9 to 9.7]. All-cause 
mortality in the CRO group was 28%, as compared to CSO group with 8% [p< 0.0001]. 
Corrected mortality in the CRO group was also significantly higher [52.8% vs 18.5%, 
p<0.0001]. Resistance to Tigecycline in addition to carbapenems in CRO sepsis was 
associated with 70% mortality.   
 
CONCLUSIONS: The high mortality in children with carbapenem-resistant sepsis                                 
even with appropriate antibiotic therapy, and the advent of pan-resistant gram-negative 
infections, leads to the conclusion that prevention of spread of these highly virulent 
organisms in the hospital and community should be a cornerstone of management of 
carbapenem resistance. 
